Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités 19 out 2023 Nouveaux fonds pour le traitement de régénération tissulaire de Mimix Biotherapeutics La société biennoise Mimix Biotherapeutics a annoncé la clôture d’un important tour d’investissement, auquel ont participé des investisseurs euro...
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 18 mar 2024 Neuria enters Vanguard Accelerator to gameify healthier lifestyles Neuria Digital Therapeutics has become the inaugural start-up of 2024 to be embraced by the Vanguard Accelerator program.
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités 26 mar 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
Actualités 12 jan 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
Actualités 18 mar 2024 Neuria intègre l’accélérateur Vanguard pour promouvoir des modes de vie plus sains Neuria Digital Therapeutics est la première start-up de 2024 à bénéficier du programme Vanguard Accelerator.
News 24 mai 2024 Health Innovation Hub drives medical innovation Switzerland Innovation Park East has opened its Health Innovation Hub in St.Gallen. The hub serves as a platform for initiating, promoting and ac...
Actualités 30 mai 2023 Une interface cerveau-machine redonne la mobilité à un paraplégique Des chercheurs de l’EPFL/CHUV/UNIL et CEA/CHUGA/UGA ont conçu une interface cerveau-machine qui a permis à un patient paraplégique de contrôler s...
News 29 nov 2023 Western Switzerland medtech start-ups embark on human trials Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical...
News 07 jun 2022 Endodentics specialist Lumendo scores oversubscribed investment round A disruptor in the field of endodentics, Lumendo has announced the oversubscription of their financing round, bringing the total amount raised to...
News 30 abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Actualités 29 nov 2023 Des start-ups medtech de Suisse occidentale démarrent leurs essais sur l’homme Des start-ups medtech de Suisse occidentale font des progrès significatifs dans le domaine de la santé, en proposant des solutions innovantes pou...
News 11 out 2023 Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine In a stride towards redefining regenerative medicine, Monash University collaborates with Valais-based Orio Therapeutics to innovate in the realm...
News 16 ago 2022 OnlineDoctor puts electronic prescriptions to the test For the first time, dermatologists can issue electronic prescriptions for their patients via the OnlineDoctor platform. For this, the St.Gallen p...